期刊
CURRENT OPINION IN BIOMEDICAL ENGINEERING
卷 13, 期 -, 页码 9-15出版社
ELSEVIER
DOI: 10.1016/j.cobme.2019.08.005
关键词
Cell-free; Biosensors; TXTL; Point-of-care; Diagnostics
资金
- ERC starting grant COMPUCELL
- INSERM Atip-Avenir program
- Bettencourt-Schueller Foundation
- French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]
Recent years have witnessed a rapid increase of the use of cell-free systems for biosensor engineering. Building on the past decade of synthetic biology research mostly performed in living cells, researchers have developed a variety of cell-free applications capable of detecting antibiotics, clinical biomarkers, or nucleic acid sequences from viral and bacterial pathogens. Cell-free systems allow for simple fine-tuning of circuit component stoichiometry and provide a nonliving alternative to whole-cell biosensors that could expedite their path through regulatory approval. In addition, many of these systems have been shown to exhibit increased stability upon lyophilization, potentially enabling point-of-care applications and use in low-resource settings where continuous cold-chain maintenance may be difficult. Here, we discuss the latest advances in cell-free biosensor research and highlight some key challenges to address for the field to bring its full potential.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据